Sign in
Taking peopleNo phase

Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer

Key facts

Who runs it
Copenhagen University Hospital, Rigshospitalet
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
1 May 2023
Expected to end
1 Jul 2027
Type of study
Observational
Record updated
13 December 2023

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients with vulva cancer, tumor > 4 cm, multifocal tumor, or local recurrences in vulva

Who cannot take part

  • Previous external irradiation of the vulva or groins
  • Known allergy to ICG or iodine
  • Patient is in active treatment for other cancer and/or disseminated disease
  • Former sentinel node or inguinal lymphadenectomy in the relevant groin

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with vulva cancer tumour size >4 cm, multifocal tumors and local recurrences.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer ( SENTIVUC II)
Record updated
13 December 2023